Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

UN Hears Major Differences on Global Approach to Drug Abuse

By Drug Discovery Trends Editor | April 22, 2016

Jamaica's Minister for Foreign Affairs and Foreign Trade Kamina Johnson Smith addresses the United Nations special session on global drug policy, Wednesday April 20, 2016 at U.N. headquarters. (AP Photo/Bebeto Matthews)Jamaica defended its decriminalization of possession of small amounts of marijuana. Iran said it seized 620 tons of different types of drugs last year and is helping protect the world from “the evils of addiction.” Cuba opposed the legalization of drugs or declaring them harmless.

The first U.N. General Assembly special session to address global drug policy in nearly 20 years heard major differences on the approach to drug use on its second day on Wednesday.

On the liberalization side, Canada’s Health Minister Jane Philpott announced that the government will introduce legislation to legalize marijuana next spring. She said Canada will ensure that marijuana is kept out children’s hands, and will address the devastating consequences of drugs and drug-related crimes.

Jamaica’s Foreign Minister Kamina Johnson Smith told delegates that the government amended the Dangerous Drugs Act last year to give tickets for possession of less than two ounces of cannabis instead of making it a felony offense, and to legalize the sacramental use of marijuana by Rastafarians. It also established provisions for the medical, scientific and therapeutic uses of the plant, she said.

Smith said Jamaica is finalizing a five-year national drug plan including programs to reduce demand for drugs, provide for early intervention and treatment of drug users, and promote rehabilitation and social reintegration.

Michael Botticelli, director of the White House Office of National Drug Control Policy, stressed that “law enforcement efforts should focus on criminal organizations – not on people with substance use disorders who need treatment and recovery support services.”

He called for drug policies in every country to address the needs of underserved groups including women and children, indigenous people, prisoners, and lesbians, gays, bisexual and transgender people.

On the tough enforcement side, Indonesia’s Ambassador Rachmat Budiman said “a zero-tolerance approach” is needed to suppress and eliminate the scourge of drugs.

He said drug trafficking rings are using new “psychoactive substances” and the Internet to penetrate all levels of society, including the young generation, and pose “a serious threat which requires extraordinary efforts.”

Like Indonesia, Iran imposes the death penalty on drug traffickers.

Iran’s Justice Minister Abdulreza Rahmani Fazli told the high-level meeting that the Islamic Republic has spent billions of dollars in its campaign against armed drug traffickers.

He said Iran is ready to host an international conference on countering drugs and drug-related crimes along the Balkan route, one of the two main heroin trafficking corridors linking opium-producing Afghanistan to the huge markets of Russia and Western Europe. It usually goes through Pakistan to Iran, Turkey, Greece and Bulgaria across southeastern Europe to the Western European market, and has an annual market value of some $28 billion, according to the U.N. Office of Drugs and Crime known as UNODC.

Fazli said the conference, in collaboration with the UNODC and countries on the route, would tackle ways to combat drug-related money laundering and detect drug trafficking ringleaders.

Cuba’s Justice Minister Maria Esther Reus Gonzalez asked how the world couldn’t be worried when the world drug problem has become “deeper and more intensified” with 246 million people using illicit drugs, according to UNODC.

“It will be really difficult to solve the problems of mass production of and trafficking in drugs from the South, if the majority demand from the North is not eliminated,” she warned.

Reus Gonzalez also warned that legalizing drugs won’t solve the problem either and will only open “more dangerous gaps for the stability of our nations.” She reiterated “Cuba’s absolutely commitment to achieving societies free of illicit drugs.”

Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50